Harmony Biosciences Holdings, Inc. (HRMY) has a market capitalization of $1.69B and trades at $29.29. The 52-week range is 25.52-40.87.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.6, Earnings Per Share (EPS) of $2.76, annual revenue of $868.45M.
The stock has a beta of 0.89, operates in the Healthcare sector.
